Dr. Reddy's Signs Agreement to Market Bicodex Products in Romania

by Benzinga Staff
November 4, 2015 4:16 AM | 1 min read | Make a Comment

Crypto Whales Are Loading Up — Are You?

New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.

Dr. Reddy's Laboratories (NYSE: RDY) has entered into a strategic alliance with Biocodex to market and distribute Biocodex products in the Romanian market. Biocodex has announced the change in partnership and effective October 1, 2015, Dr. Reddy's has been given the complete rights for promotion and distribution of the Biocodex products across Romania. Earlier, AKACIA was in partnership with Biocodex for similar distribution pact. With this new collaboration coming into existence, Dr. Reddy's will aim to develop the access of the Romanian patients to the Rx portfolio including Biocodex's well-known OTC products ENTEROL and OTIPAX. ENTEROL: The ethical pharmaceutical specialty composed of lyophilised See full press release

Crypto Whales Are Loading Up — Are You?

New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.

ENTER TO WIN $500 IN STOCK OR CRYPTO

Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!

Posted In: NewsContractsPress Releases

© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.